James Singer, MD, is a gastroenterologist with Glendale-based Arizona Digestive Health.
GI & Endoscopy
The Expert Network recognized gastroenterologist Jonathan C. Ellis, MD.
Laval, Canada-based Valeant's move to sell $2.1 billion in assets in January 2017 positively impacted its debt pathway, SeekingAlpha reports.
After receiving multiple adverse events reports, the FDA wrote a letter to providers urging for heightened patient monitoring.
The following GI companies have made headlines this week, with Japan-based Takeda Pharmaceuticals facing the revival of an antitrust case.
Brij M. Dewan, MD, is a gastroenterologist and founder of Kalamazoo (Mich.) Gastroenterology.
A study published in PLOS One researched vitamin D's effect in children with irritable bowel syndrome.
Japan-based Takeda donated $1 million to Cambridge, Mass.-based Koch Institute for integrative cancer research.
After the recent flood of duodenoscope-related deaths, Eric Chaffin, an attorney at New York City-based Chaffin Luhana, penned a column for the Legal Examiner examining if disposable duodenoscopes could limit infection risks.
European Union-based OncoTrack researchers possibly discovered biomarkers that could predict two drugs's effectiveness in treating common bowel cancer, News-Medical reports.
